{
    "nct_id": "NCT05127915",
    "official_title": "A Prospective, Multicenter, Pivotal Study With Randomized Controlled Prophylactic and Independent Therapeutic Cohorts to Evaluate the Safety and Efficacy of an Absorbable Vena Cava Filter for Pulmonary Embolism Prevention",
    "inclusion_criteria": "INCLUSION CRITERIA:\n\nAged 18 years or older\n\nWilling to comply with the specified follow-up requirements including contrast enhanced CTs for the 9-month duration of the study\n\nFor female subjects of childbearing potential: a negative pregnancy test within 48 hours prior to the implantation procedure\n\nFor the prophylactic cohort, high risk VTE denoted by either:\n\nCaprini score > 8 for surgical ICU, Parvizi score ≥ 150 for TKA (total knee replacement), ISS score ≥ 24 for trauma.\n\nFor the therapeutic cohort, documented VTE per the following:\n\nPulmonary thromboembolism when anticoagulants are contraindicated, Failure of anticoagulant therapy in thromboembolic diseases, Emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced.\n\nRequirement of temporary PE protection (8 weeks) based on clinical judgment\n\nFully informed subject or caretaker consent having executed an Institutional Review Board (IRB) or approved informed consent.\n\nEXCLUSION CRITERIA:\n\nExpected high VTE risk to extend beyond 8 weeks.\n\nVena cava filter currently implanted\n\nHistory of abdominal or pelvic radiation therapy\n\nPrevious IVC filter placement/retrieval within 6 months prior to randomization\n\nConfirmed positive blood cultures within the last 48 hours if there is bacteremia\n\nKnown sensitivity to radiographic contrast medium that cannot be adequately prophylactically pre-medicated\n\nKnown allergy or intolerance to IVC filter materials (i.e. PDSII absorbable suture)\n\nPregnant, lactating, or plans to become pregnant during investigation follow-up period\n\nRenal insufficiency (GFR < 60) or requiring renal replacement therapy\n\nIVC effective diameter (D) <16 mm or >28 mm anywhere within L1-L4, D = √(AP*Lat)\n\nLess than 7cm from inferior-most renal vein to the iliac vein confluence\n\nDuplication of the IVC\n\nAny thrombus or occlusion in IVC on pre-procedural CT cavogram\n\nLife expectancy of < 12 months\n\nSimultaneous participation in another investigative drug or device trial that has not reached its primary endpoint\n\nOther co-morbid condition that, in the opinion of the Investigator, could limit the subject's ability to participate in or would affect the scientific integrity of the study\n\nPreviously enrolled in a clinical investigation of the Adient filter.\n\nFor Roll In, patient has advanced heart failure or recent (6 weeks) myocardial infarction. - - -\n\nAdvanced heart failure is defined by NYHA class IV or AHA/ACC/HFSA stage D or LVEF < 40%. Subjects with MI diagnosed with ECG alone without MI history and symptoms are not excluded.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}